更多資訊 ― 繁體中文

Urticaria 通常會出現劇烈搔癢的凸起傷痕。有時伴隨皮下組織腫脹。治療主要包括避免觸發因素（如果已知）。第一線藥物包括新型抗組織胺藥，如果需要，可以調整至更高劑量。其他藥物如較舊的抗組織胺、H2 阻斷劑、白三烯受體拮抗劑、更強的抗組織胺和短期皮質類固醇可以作為額外支持。如果儘管採取了這些措施，蕁麻疹仍然存在，患者可能會被轉介給專家進行額外的治療，例如 omalizumab 或 cyclosporine 。
Urticaria commonly presents with intensely itchy raised welts. It is sometimes accompanied by swelling of the underlying tissues. Treatment primarily involves avoiding triggers, if known. First-line medication includes newer antihistamines, which can be adjusted to higher doses if needed. Other medications like older antihistamines, H2 blockers, leukotriene receptor antagonists, stronger antihistamines, and short courses of corticosteroids can be added as extra support. In cases where urticaria persists despite these measures, patients might be referred to specialists for additional therapies such as omalizumab or cyclosporine.

這篇綜述概述了治療蕁麻疹的最新指南，並提供了對其病因的新認識。
This review outlines the latest guidelines for treating urticaria and offers new understandings of its causes.

Second-generation H1-antihistamines (e.g., cetirizine, loratadine, fexofenadine), Omalizumab, Ciclosporin, and short courses only of systemic corticosteroids